The two facilities will generate a combined production capacity of up to 51 metric tonnes per year, which will position Tilray to respond to significant projected growth in demand for its medical cannabis products.
"We are proud to offer patients one of the widest selections of GMP-grade medical cannabis products, including Tilray drops and capsules, on the market," said Philippe Lucas, Vice President of Patient Research and Access at Tilray.
On July 4, fashion favorite Colette unveiled a pop-up of Marley Natural's body care and smoking accessories. “It’s important to show people that cannabis has so many uses beyond smoking,” said Bob Marley's granddaughter Zuri Marley, who made her first trip to Paris for the launch.
As legalization takes hold, it will be incumbent upon cannabis brands to lead the way. “Sitting on the sidelines isn't an option for us because activism is inherent to everything we do,” explains Zack Hutson, Vice President of Corporate Affairs at Privateer Holdings.
Pharmacies in Chile's capital will start selling cannabis-based medicines this week, the first time such treatments have been offered by drug stores in Latin America. Canadian cannabis producer and distributor Tilray partnered with local firm Alef Biotechnology, which is licensed by the Chilean government.
Global company Tilray, which produces and distributes medical cannabis around the world, has received clearance to send cannabinoid formulations to patients in Cyprus. The product is a medical cannabis extract targeting patients with advanced cases of cancer.
Tilray President Brendan Kennedy said his company would ask that producers be allowed to develop brands through distinctive packaging. “Otherwise it will be a race to the bottom, as companies will compete only based on potency and price,” he said.